We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

28 hedge funds and large institutions have $9.94M invested in Sanara MedTech in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more capital invested

Capital invested by funds: $5.45M → $9.94M (+$4.49M)

33% more funds holding

Funds holding: 21 → 28 (+7)

0.76% more ownership

Funds ownership: 3.27% → 4.03% (+0.76%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EI
EAM Investors
California
+$1.54M
2
State Street
State Street
Massachusetts
+$224K
3
QC
Quadrature Capital
United Kingdom
+$193K
4
Citadel Advisors
Citadel Advisors
Florida
+$109K
5
Morgan Stanley
Morgan Stanley
New York
+$57.2K

Top Sellers

Rank Fund Capital Flow
1
PCM
Prelude Capital Management
New York
-$124K
2
Lazard Asset Management
Lazard Asset Management
New York
-$28.4K
3
TRCT
Tower Research Capital (TRC)
New York
-$22.3K
4
DC
Diametric Capital
Massachusetts
-$17.7K
5
BlackRock
BlackRock
New York
-$7.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.74M +$2.8K +100 +0.1%
EI
2
EAM Investors
California
$1.63M +$1.54M +54,860 New
DC
3
Diametric Capital
Massachusetts
$882K -$17.7K -633 -2%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$783K +$31.7K +1,133 +4%
NRC
5
North Run Capital
Massachusetts
$713K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$440K +$109K +3,878 +35%
CAPTRUST Financial Advisors
7
CAPTRUST Financial Advisors
North Carolina
$438K – – –
LCM
8
Laurion Capital Management
New York
$350K – – –
PCM
9
Prelude Capital Management
New York
$335K -$124K -4,439 -28%
SIC
10
Salem Investment Counselors
North Carolina
$333K – – –
State Street
11
State Street
Massachusetts
$238K +$224K +8,013 New
BlackRock
12
BlackRock
New York
$224K -$7.67K -274 -4%
QC
13
Quadrature Capital
United Kingdom
$204K +$193K +6,887 New
New York State Common Retirement Fund
14
New York State Common Retirement Fund
New York
$171K – – –
Rockefeller Capital Management
15
Rockefeller Capital Management
New York
$163K – – –
Morgan Stanley
16
Morgan Stanley
New York
$96K +$57.2K +2,044 +172%
First Manhattan
17
First Manhattan
New York
$47K +$47.6K +1,700 New
Citigroup
18
Citigroup
New York
$28K +$26.5K +946 New
BAMCO Inc
19
BAMCO Inc
New York
$26K +$24.2K +864 New
Bank of America
20
Bank of America
North Carolina
$23K – – –
Lazard Asset Management
21
Lazard Asset Management
New York
$22K -$28.4K -1,016 -58%
ARS
22
Adirondack Retirement Specialists
New York
$17K +$15.9K +567 New
LF
23
Lee Financial
Texas
$15K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$11K -$22.3K -798 -69%
UBS Group
25
UBS Group
Switzerland
$6K -$5.8K -207 -51%
1
2

SMTI Hedge Fund Activity: Q3 2022 in Review

28 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2022, worth a combined $9.94M — up 82% from $5.45M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SMTI positions and 0 closed out — a net gain of 7 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.54M. The largest seller was Prelude Capital Management, cutting an estimated $124K.

  • 28 institutional investors held Sanara MedTech (SMTI) as of Q3 2022, up from 21 in Q2 2022.
  • Funds reported $9.94M of Sanara MedTech stock for Q3 2022, up 82% quarter-over-quarter.
  • 7 funds opened new Sanara MedTech positions in Q3 2022 and 0 closed out, a net change of +7 holders.
  • The largest Sanara MedTech buyer in Q3 2022 was EAM Investors, an estimated $1.54M added.
  • The largest Sanara MedTech seller in Q3 2022 was Prelude Capital Management, an estimated $124K sold.

Based on aggregated 13F filings for Q3 2022.